Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Melatonin in Lennox-Gastaut Syndrome
NCT01370486Phase 4Withdrawn
- Sponsor
- Institution de Lavigny
- Start
- Aug 2011
- Primary completion
- Jan 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of melatonin in Lennox-Gastaut syndrome (LGS), sponsored by Institution de Lavigny. Planned start Aug 2011; status: withdrawn.
02
Drugs
melatonin
03
Conditions
Lennox-Gastaut syndrome (LGS)
Beyond the preview
Go deeper on NCT01370486.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01370486.